High Price | GenomeWeb

High Price

The public is increasingly concerned about the high price tags of pharmaceuticals, and David Blumenthal, president of the national health-care philanthropy the Commonwealth Fund, writes at the Wall Street Journal that personalized medicines are contributing to those high costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.